Javelin’s Dyloject On Track For 1H 2009 NDA Filing; PMI-150 Needs Additional Efficacy Study
This article was originally published in The Pink Sheet Daily
Executive Summary
Following Dec. U.K. Dyloject launch, firm plans to market the NSAID in other European markets during the second half of next year.